Davina McCall was moved to tears when a cancer patient at Addenbrooke's Hospital asked her how she was doing during the Cancer Clinic Live segment for Stand Up To Cancer 2025 on Friday.
The TV presenter was filming a Stand Up to Cancer special at Addenbrooke's Hospital in Cambridge when she had an emotional encounter with patient Stuart
(MedPage Today) -- SAN ANTONIO -- Many patients with early breast cancer can safely skip sentinel lymph node biopsy (SLNB), results of a large Dutch study suggested.
(MedPage Today) -- SAN ANTONIO -- Preoperative MRI for staging patients with early, hormone receptor (HR)-negative breast cancer didn't result in improved oncologic outcomes or improved clinical care, according to a phase III study…
As the nation waits to hear King Charles' personal address to the nation this evening, the Mirror takes a look back on the monarch's cancer journey so far, from his return to public life to his warm chats with fellow patients
A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered tailored support by monitoring electronic patient-reported outcomes (ePROs) significantly improved quality of life and symptoms…
A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered tailored support by monitoring electronic patient-reported outcomes (ePROs) significantly improved quality of life and symptoms…
Subset analyses show broad activity in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer, regardless of prior fulvestrant or other SERD exposure, or ESR1 mutation status
Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence whether or not they underwent preoperative breast magnetic resonance imaging (MRI) in addition to diagnostic…
The new regulatory innovation corridor aims to speed up patient access to breakthrough therapies in high-impact areas, such as cancer, dementia, obesity, rare diseases and advanced diagnostics.
A new study published today in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with traditional radiation therapy (IMRT).
Cancer immunotherapy has transformed cancer treatment, yet many patients experience limited or short-lived responses due to immune evasion, tumor heterogeneity, and immune-related adverse events.
Patient survey finds that those engaged in shared decision-making were 11 times more likely to report higher satisfaction with their treatments, with 90% of lung cancer patients in Japan wanting to play an active role in their treatment…
A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with traditional radiation therapy (IMRT).
A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone receptor-positive (HR+) metastatic breast…